5
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP1111 | Tirzepatide | LY-3298176 | Glucagon Receptor |
Tirzepatide (LY-3298176) is a dual agonist of glucose-dependent polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor with neuroprotective activity for the study of diabetes and obesity. | |||
T83906 | Tirzepatide sodium | LY3298176 | |
Tirzepatide acts as an agonist for both the glucagon-like peptide 1 receptor (GLP-1R) and G protein-coupled receptor 119 (GPR119), effectively inducing cAMP production in HEK293 cells that express either human GLP-1R or ... | |||
TP1110 | Tirzepatide hydrochloride | LY3298176 hydrochloride | |
Tirzepatide hydrochloride (LY3298176 hydrochloride) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. | |||
T76006 | Tirzepatide TFA | Tirzepatide TFA(2023788-19-2 free base),LY3298176 TFA | |
Tirzepatide TFA (LY3298176 TFA), a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, is under development for type 2 diabetes treatment [1]. | |||
TP1111L1 | Tirzepatide sodium salt | LY-3298176 sodium salt,Tirzepatide sodium salt(2023788-19-2 free base) | Glucagon Receptor |
Tirzepatide sodium salt (LY3298176 sodium salt) is a GIP and GLP-1 receptor agonist with neuroprotective activity and can be used to treat obesity. |